Medical Care
Global CD98 Antibody Market Research Report 2025
- May 12, 25
- ID: 236053
- Pages: 96
- Figures: 100
- Views: 3
The global market for CD98 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CD98 Antibody (E-5) is a mouse monoclonal IgG1 κ CD98 antibody, cited in 18 publications, provided at 200 µg/ml. raised against amino acids 230-529 of CD98 of human origin. CD98 Antibody (E-5) is recommended for detection of CD98 of human origin by WB, IP, IF, IHC(P) and ELISA.
North American market for CD98 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD98 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CD98 Antibody in Immunochemistry (IHC) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CD98 Antibody include Merck, Thermo Fisher Scientific, Bioss, Proteintech Group, Aviva Systems Biology, Leading Biology, RayBiotech, ABclonal Technology, OriGene Technologies, Novus Biologicals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD98 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD98 Antibody.
The CD98 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD98 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD98 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
Bioss
Proteintech Group
Aviva Systems Biology
Leading Biology
RayBiotech
ABclonal Technology
OriGene Technologies
Novus Biologicals
R&D Systems
AssayPro
Abnova Corporation
Sino Biological
Biomatik
CUSABIO Technology
Affinity Biosciences
Creative Biolabs
Jingjie PTM BioLab
Beijing Solarbio
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD98 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CD98 Antibody (E-5) is a mouse monoclonal IgG1 κ CD98 antibody, cited in 18 publications, provided at 200 µg/ml. raised against amino acids 230-529 of CD98 of human origin. CD98 Antibody (E-5) is recommended for detection of CD98 of human origin by WB, IP, IF, IHC(P) and ELISA.
North American market for CD98 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD98 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CD98 Antibody in Immunochemistry (IHC) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CD98 Antibody include Merck, Thermo Fisher Scientific, Bioss, Proteintech Group, Aviva Systems Biology, Leading Biology, RayBiotech, ABclonal Technology, OriGene Technologies, Novus Biologicals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD98 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD98 Antibody.
The CD98 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD98 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD98 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
Bioss
Proteintech Group
Aviva Systems Biology
Leading Biology
RayBiotech
ABclonal Technology
OriGene Technologies
Novus Biologicals
R&D Systems
AssayPro
Abnova Corporation
Sino Biological
Biomatik
CUSABIO Technology
Affinity Biosciences
Creative Biolabs
Jingjie PTM BioLab
Beijing Solarbio
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD98 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD98 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD98 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD98 Antibody Market Perspective (2020-2031)
2.2 Global CD98 Antibody Growth Trends by Region
2.2.1 Global CD98 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD98 Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD98 Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD98 Antibody Market Dynamics
2.3.1 CD98 Antibody Industry Trends
2.3.2 CD98 Antibody Market Drivers
2.3.3 CD98 Antibody Market Challenges
2.3.4 CD98 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD98 Antibody Players by Revenue
3.1.1 Global Top CD98 Antibody Players by Revenue (2020-2025)
3.1.2 Global CD98 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD98 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD98 Antibody Revenue
3.4 Global CD98 Antibody Market Concentration Ratio
3.4.1 Global CD98 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD98 Antibody Revenue in 2024
3.5 Global Key Players of CD98 Antibody Head office and Area Served
3.6 Global Key Players of CD98 Antibody, Product and Application
3.7 Global Key Players of CD98 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD98 Antibody Breakdown Data by Type
4.1 Global CD98 Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD98 Antibody Forecasted Market Size by Type (2026-2031)
5 CD98 Antibody Breakdown Data by Application
5.1 Global CD98 Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD98 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD98 Antibody Market Size (2020-2031)
6.2 North America CD98 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD98 Antibody Market Size by Country (2020-2025)
6.4 North America CD98 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD98 Antibody Market Size (2020-2031)
7.2 Europe CD98 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD98 Antibody Market Size by Country (2020-2025)
7.4 Europe CD98 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD98 Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD98 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD98 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD98 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD98 Antibody Market Size (2020-2031)
9.2 Latin America CD98 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD98 Antibody Market Size by Country (2020-2025)
9.4 Latin America CD98 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD98 Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD98 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD98 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD98 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD98 Antibody Introduction
11.1.4 Merck Revenue in CD98 Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CD98 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in CD98 Antibody Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bioss
11.3.1 Bioss Company Details
11.3.2 Bioss Business Overview
11.3.3 Bioss CD98 Antibody Introduction
11.3.4 Bioss Revenue in CD98 Antibody Business (2020-2025)
11.3.5 Bioss Recent Development
11.4 Proteintech Group
11.4.1 Proteintech Group Company Details
11.4.2 Proteintech Group Business Overview
11.4.3 Proteintech Group CD98 Antibody Introduction
11.4.4 Proteintech Group Revenue in CD98 Antibody Business (2020-2025)
11.4.5 Proteintech Group Recent Development
11.5 Aviva Systems Biology
11.5.1 Aviva Systems Biology Company Details
11.5.2 Aviva Systems Biology Business Overview
11.5.3 Aviva Systems Biology CD98 Antibody Introduction
11.5.4 Aviva Systems Biology Revenue in CD98 Antibody Business (2020-2025)
11.5.5 Aviva Systems Biology Recent Development
11.6 Leading Biology
11.6.1 Leading Biology Company Details
11.6.2 Leading Biology Business Overview
11.6.3 Leading Biology CD98 Antibody Introduction
11.6.4 Leading Biology Revenue in CD98 Antibody Business (2020-2025)
11.6.5 Leading Biology Recent Development
11.7 RayBiotech
11.7.1 RayBiotech Company Details
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech CD98 Antibody Introduction
11.7.4 RayBiotech Revenue in CD98 Antibody Business (2020-2025)
11.7.5 RayBiotech Recent Development
11.8 ABclonal Technology
11.8.1 ABclonal Technology Company Details
11.8.2 ABclonal Technology Business Overview
11.8.3 ABclonal Technology CD98 Antibody Introduction
11.8.4 ABclonal Technology Revenue in CD98 Antibody Business (2020-2025)
11.8.5 ABclonal Technology Recent Development
11.9 OriGene Technologies
11.9.1 OriGene Technologies Company Details
11.9.2 OriGene Technologies Business Overview
11.9.3 OriGene Technologies CD98 Antibody Introduction
11.9.4 OriGene Technologies Revenue in CD98 Antibody Business (2020-2025)
11.9.5 OriGene Technologies Recent Development
11.10 Novus Biologicals
11.10.1 Novus Biologicals Company Details
11.10.2 Novus Biologicals Business Overview
11.10.3 Novus Biologicals CD98 Antibody Introduction
11.10.4 Novus Biologicals Revenue in CD98 Antibody Business (2020-2025)
11.10.5 Novus Biologicals Recent Development
11.11 R&D Systems
11.11.1 R&D Systems Company Details
11.11.2 R&D Systems Business Overview
11.11.3 R&D Systems CD98 Antibody Introduction
11.11.4 R&D Systems Revenue in CD98 Antibody Business (2020-2025)
11.11.5 R&D Systems Recent Development
11.12 AssayPro
11.12.1 AssayPro Company Details
11.12.2 AssayPro Business Overview
11.12.3 AssayPro CD98 Antibody Introduction
11.12.4 AssayPro Revenue in CD98 Antibody Business (2020-2025)
11.12.5 AssayPro Recent Development
11.13 Abnova Corporation
11.13.1 Abnova Corporation Company Details
11.13.2 Abnova Corporation Business Overview
11.13.3 Abnova Corporation CD98 Antibody Introduction
11.13.4 Abnova Corporation Revenue in CD98 Antibody Business (2020-2025)
11.13.5 Abnova Corporation Recent Development
11.14 Sino Biological
11.14.1 Sino Biological Company Details
11.14.2 Sino Biological Business Overview
11.14.3 Sino Biological CD98 Antibody Introduction
11.14.4 Sino Biological Revenue in CD98 Antibody Business (2020-2025)
11.14.5 Sino Biological Recent Development
11.15 Biomatik
11.15.1 Biomatik Company Details
11.15.2 Biomatik Business Overview
11.15.3 Biomatik CD98 Antibody Introduction
11.15.4 Biomatik Revenue in CD98 Antibody Business (2020-2025)
11.15.5 Biomatik Recent Development
11.16 CUSABIO Technology
11.16.1 CUSABIO Technology Company Details
11.16.2 CUSABIO Technology Business Overview
11.16.3 CUSABIO Technology CD98 Antibody Introduction
11.16.4 CUSABIO Technology Revenue in CD98 Antibody Business (2020-2025)
11.16.5 CUSABIO Technology Recent Development
11.17 Affinity Biosciences
11.17.1 Affinity Biosciences Company Details
11.17.2 Affinity Biosciences Business Overview
11.17.3 Affinity Biosciences CD98 Antibody Introduction
11.17.4 Affinity Biosciences Revenue in CD98 Antibody Business (2020-2025)
11.17.5 Affinity Biosciences Recent Development
11.18 Creative Biolabs
11.18.1 Creative Biolabs Company Details
11.18.2 Creative Biolabs Business Overview
11.18.3 Creative Biolabs CD98 Antibody Introduction
11.18.4 Creative Biolabs Revenue in CD98 Antibody Business (2020-2025)
11.18.5 Creative Biolabs Recent Development
11.19 Jingjie PTM BioLab
11.19.1 Jingjie PTM BioLab Company Details
11.19.2 Jingjie PTM BioLab Business Overview
11.19.3 Jingjie PTM BioLab CD98 Antibody Introduction
11.19.4 Jingjie PTM BioLab Revenue in CD98 Antibody Business (2020-2025)
11.19.5 Jingjie PTM BioLab Recent Development
11.20 Beijing Solarbio
11.20.1 Beijing Solarbio Company Details
11.20.2 Beijing Solarbio Business Overview
11.20.3 Beijing Solarbio CD98 Antibody Introduction
11.20.4 Beijing Solarbio Revenue in CD98 Antibody Business (2020-2025)
11.20.5 Beijing Solarbio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD98 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD98 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD98 Antibody Market Perspective (2020-2031)
2.2 Global CD98 Antibody Growth Trends by Region
2.2.1 Global CD98 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD98 Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD98 Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD98 Antibody Market Dynamics
2.3.1 CD98 Antibody Industry Trends
2.3.2 CD98 Antibody Market Drivers
2.3.3 CD98 Antibody Market Challenges
2.3.4 CD98 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD98 Antibody Players by Revenue
3.1.1 Global Top CD98 Antibody Players by Revenue (2020-2025)
3.1.2 Global CD98 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD98 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD98 Antibody Revenue
3.4 Global CD98 Antibody Market Concentration Ratio
3.4.1 Global CD98 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD98 Antibody Revenue in 2024
3.5 Global Key Players of CD98 Antibody Head office and Area Served
3.6 Global Key Players of CD98 Antibody, Product and Application
3.7 Global Key Players of CD98 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD98 Antibody Breakdown Data by Type
4.1 Global CD98 Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD98 Antibody Forecasted Market Size by Type (2026-2031)
5 CD98 Antibody Breakdown Data by Application
5.1 Global CD98 Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD98 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD98 Antibody Market Size (2020-2031)
6.2 North America CD98 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD98 Antibody Market Size by Country (2020-2025)
6.4 North America CD98 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD98 Antibody Market Size (2020-2031)
7.2 Europe CD98 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD98 Antibody Market Size by Country (2020-2025)
7.4 Europe CD98 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD98 Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD98 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD98 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD98 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD98 Antibody Market Size (2020-2031)
9.2 Latin America CD98 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD98 Antibody Market Size by Country (2020-2025)
9.4 Latin America CD98 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD98 Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD98 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD98 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD98 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD98 Antibody Introduction
11.1.4 Merck Revenue in CD98 Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CD98 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in CD98 Antibody Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bioss
11.3.1 Bioss Company Details
11.3.2 Bioss Business Overview
11.3.3 Bioss CD98 Antibody Introduction
11.3.4 Bioss Revenue in CD98 Antibody Business (2020-2025)
11.3.5 Bioss Recent Development
11.4 Proteintech Group
11.4.1 Proteintech Group Company Details
11.4.2 Proteintech Group Business Overview
11.4.3 Proteintech Group CD98 Antibody Introduction
11.4.4 Proteintech Group Revenue in CD98 Antibody Business (2020-2025)
11.4.5 Proteintech Group Recent Development
11.5 Aviva Systems Biology
11.5.1 Aviva Systems Biology Company Details
11.5.2 Aviva Systems Biology Business Overview
11.5.3 Aviva Systems Biology CD98 Antibody Introduction
11.5.4 Aviva Systems Biology Revenue in CD98 Antibody Business (2020-2025)
11.5.5 Aviva Systems Biology Recent Development
11.6 Leading Biology
11.6.1 Leading Biology Company Details
11.6.2 Leading Biology Business Overview
11.6.3 Leading Biology CD98 Antibody Introduction
11.6.4 Leading Biology Revenue in CD98 Antibody Business (2020-2025)
11.6.5 Leading Biology Recent Development
11.7 RayBiotech
11.7.1 RayBiotech Company Details
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech CD98 Antibody Introduction
11.7.4 RayBiotech Revenue in CD98 Antibody Business (2020-2025)
11.7.5 RayBiotech Recent Development
11.8 ABclonal Technology
11.8.1 ABclonal Technology Company Details
11.8.2 ABclonal Technology Business Overview
11.8.3 ABclonal Technology CD98 Antibody Introduction
11.8.4 ABclonal Technology Revenue in CD98 Antibody Business (2020-2025)
11.8.5 ABclonal Technology Recent Development
11.9 OriGene Technologies
11.9.1 OriGene Technologies Company Details
11.9.2 OriGene Technologies Business Overview
11.9.3 OriGene Technologies CD98 Antibody Introduction
11.9.4 OriGene Technologies Revenue in CD98 Antibody Business (2020-2025)
11.9.5 OriGene Technologies Recent Development
11.10 Novus Biologicals
11.10.1 Novus Biologicals Company Details
11.10.2 Novus Biologicals Business Overview
11.10.3 Novus Biologicals CD98 Antibody Introduction
11.10.4 Novus Biologicals Revenue in CD98 Antibody Business (2020-2025)
11.10.5 Novus Biologicals Recent Development
11.11 R&D Systems
11.11.1 R&D Systems Company Details
11.11.2 R&D Systems Business Overview
11.11.3 R&D Systems CD98 Antibody Introduction
11.11.4 R&D Systems Revenue in CD98 Antibody Business (2020-2025)
11.11.5 R&D Systems Recent Development
11.12 AssayPro
11.12.1 AssayPro Company Details
11.12.2 AssayPro Business Overview
11.12.3 AssayPro CD98 Antibody Introduction
11.12.4 AssayPro Revenue in CD98 Antibody Business (2020-2025)
11.12.5 AssayPro Recent Development
11.13 Abnova Corporation
11.13.1 Abnova Corporation Company Details
11.13.2 Abnova Corporation Business Overview
11.13.3 Abnova Corporation CD98 Antibody Introduction
11.13.4 Abnova Corporation Revenue in CD98 Antibody Business (2020-2025)
11.13.5 Abnova Corporation Recent Development
11.14 Sino Biological
11.14.1 Sino Biological Company Details
11.14.2 Sino Biological Business Overview
11.14.3 Sino Biological CD98 Antibody Introduction
11.14.4 Sino Biological Revenue in CD98 Antibody Business (2020-2025)
11.14.5 Sino Biological Recent Development
11.15 Biomatik
11.15.1 Biomatik Company Details
11.15.2 Biomatik Business Overview
11.15.3 Biomatik CD98 Antibody Introduction
11.15.4 Biomatik Revenue in CD98 Antibody Business (2020-2025)
11.15.5 Biomatik Recent Development
11.16 CUSABIO Technology
11.16.1 CUSABIO Technology Company Details
11.16.2 CUSABIO Technology Business Overview
11.16.3 CUSABIO Technology CD98 Antibody Introduction
11.16.4 CUSABIO Technology Revenue in CD98 Antibody Business (2020-2025)
11.16.5 CUSABIO Technology Recent Development
11.17 Affinity Biosciences
11.17.1 Affinity Biosciences Company Details
11.17.2 Affinity Biosciences Business Overview
11.17.3 Affinity Biosciences CD98 Antibody Introduction
11.17.4 Affinity Biosciences Revenue in CD98 Antibody Business (2020-2025)
11.17.5 Affinity Biosciences Recent Development
11.18 Creative Biolabs
11.18.1 Creative Biolabs Company Details
11.18.2 Creative Biolabs Business Overview
11.18.3 Creative Biolabs CD98 Antibody Introduction
11.18.4 Creative Biolabs Revenue in CD98 Antibody Business (2020-2025)
11.18.5 Creative Biolabs Recent Development
11.19 Jingjie PTM BioLab
11.19.1 Jingjie PTM BioLab Company Details
11.19.2 Jingjie PTM BioLab Business Overview
11.19.3 Jingjie PTM BioLab CD98 Antibody Introduction
11.19.4 Jingjie PTM BioLab Revenue in CD98 Antibody Business (2020-2025)
11.19.5 Jingjie PTM BioLab Recent Development
11.20 Beijing Solarbio
11.20.1 Beijing Solarbio Company Details
11.20.2 Beijing Solarbio Business Overview
11.20.3 Beijing Solarbio CD98 Antibody Introduction
11.20.4 Beijing Solarbio Revenue in CD98 Antibody Business (2020-2025)
11.20.5 Beijing Solarbio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CD98 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD98 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CD98 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CD98 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CD98 Antibody Market Share by Region (2020-2025)
Table 8. Global CD98 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CD98 Antibody Market Share by Region (2026-2031)
Table 10. CD98 Antibody Market Trends
Table 11. CD98 Antibody Market Drivers
Table 12. CD98 Antibody Market Challenges
Table 13. CD98 Antibody Market Restraints
Table 14. Global CD98 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CD98 Antibody Market Share by Players (2020-2025)
Table 16. Global Top CD98 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD98 Antibody as of 2024)
Table 17. Ranking of Global Top CD98 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CD98 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CD98 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD98 Antibody, Product and Application
Table 21. Global Key Players of CD98 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD98 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CD98 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global CD98 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CD98 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global CD98 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CD98 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global CD98 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CD98 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America CD98 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CD98 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CD98 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CD98 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CD98 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CD98 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CD98 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CD98 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CD98 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD98 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CD98 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CD98 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CD98 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CD98 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CD98 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck CD98 Antibody Product
Table 49. Merck Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CD98 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Bioss Company Details
Table 57. Bioss Business Overview
Table 58. Bioss CD98 Antibody Product
Table 59. Bioss Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 60. Bioss Recent Development
Table 61. Proteintech Group Company Details
Table 62. Proteintech Group Business Overview
Table 63. Proteintech Group CD98 Antibody Product
Table 64. Proteintech Group Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 65. Proteintech Group Recent Development
Table 66. Aviva Systems Biology Company Details
Table 67. Aviva Systems Biology Business Overview
Table 68. Aviva Systems Biology CD98 Antibody Product
Table 69. Aviva Systems Biology Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 70. Aviva Systems Biology Recent Development
Table 71. Leading Biology Company Details
Table 72. Leading Biology Business Overview
Table 73. Leading Biology CD98 Antibody Product
Table 74. Leading Biology Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 75. Leading Biology Recent Development
Table 76. RayBiotech Company Details
Table 77. RayBiotech Business Overview
Table 78. RayBiotech CD98 Antibody Product
Table 79. RayBiotech Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 80. RayBiotech Recent Development
Table 81. ABclonal Technology Company Details
Table 82. ABclonal Technology Business Overview
Table 83. ABclonal Technology CD98 Antibody Product
Table 84. ABclonal Technology Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 85. ABclonal Technology Recent Development
Table 86. OriGene Technologies Company Details
Table 87. OriGene Technologies Business Overview
Table 88. OriGene Technologies CD98 Antibody Product
Table 89. OriGene Technologies Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 90. OriGene Technologies Recent Development
Table 91. Novus Biologicals Company Details
Table 92. Novus Biologicals Business Overview
Table 93. Novus Biologicals CD98 Antibody Product
Table 94. Novus Biologicals Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 95. Novus Biologicals Recent Development
Table 96. R&D Systems Company Details
Table 97. R&D Systems Business Overview
Table 98. R&D Systems CD98 Antibody Product
Table 99. R&D Systems Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 100. R&D Systems Recent Development
Table 101. AssayPro Company Details
Table 102. AssayPro Business Overview
Table 103. AssayPro CD98 Antibody Product
Table 104. AssayPro Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 105. AssayPro Recent Development
Table 106. Abnova Corporation Company Details
Table 107. Abnova Corporation Business Overview
Table 108. Abnova Corporation CD98 Antibody Product
Table 109. Abnova Corporation Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 110. Abnova Corporation Recent Development
Table 111. Sino Biological Company Details
Table 112. Sino Biological Business Overview
Table 113. Sino Biological CD98 Antibody Product
Table 114. Sino Biological Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 115. Sino Biological Recent Development
Table 116. Biomatik Company Details
Table 117. Biomatik Business Overview
Table 118. Biomatik CD98 Antibody Product
Table 119. Biomatik Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 120. Biomatik Recent Development
Table 121. CUSABIO Technology Company Details
Table 122. CUSABIO Technology Business Overview
Table 123. CUSABIO Technology CD98 Antibody Product
Table 124. CUSABIO Technology Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 125. CUSABIO Technology Recent Development
Table 126. Affinity Biosciences Company Details
Table 127. Affinity Biosciences Business Overview
Table 128. Affinity Biosciences CD98 Antibody Product
Table 129. Affinity Biosciences Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 130. Affinity Biosciences Recent Development
Table 131. Creative Biolabs Company Details
Table 132. Creative Biolabs Business Overview
Table 133. Creative Biolabs CD98 Antibody Product
Table 134. Creative Biolabs Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 135. Creative Biolabs Recent Development
Table 136. Jingjie PTM BioLab Company Details
Table 137. Jingjie PTM BioLab Business Overview
Table 138. Jingjie PTM BioLab CD98 Antibody Product
Table 139. Jingjie PTM BioLab Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 140. Jingjie PTM BioLab Recent Development
Table 141. Beijing Solarbio Company Details
Table 142. Beijing Solarbio Business Overview
Table 143. Beijing Solarbio CD98 Antibody Product
Table 144. Beijing Solarbio Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 145. Beijing Solarbio Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. CD98 Antibody Picture
Figure 2. Global CD98 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD98 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global CD98 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CD98 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. CD98 Antibody Report Years Considered
Figure 15. Global CD98 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CD98 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CD98 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global CD98 Antibody Market Share by Players in 2024
Figure 19. Global Top CD98 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD98 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CD98 Antibody Revenue in 2024
Figure 21. North America CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CD98 Antibody Market Share by Country (2020-2031)
Figure 23. United States CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CD98 Antibody Market Share by Country (2020-2031)
Figure 27. Germany CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CD98 Antibody Market Share by Region (2020-2031)
Figure 35. China CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CD98 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CD98 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 52. Bioss Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 53. Proteintech Group Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 54. Aviva Systems Biology Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 55. Leading Biology Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 56. RayBiotech Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 57. ABclonal Technology Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 58. OriGene Technologies Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 59. Novus Biologicals Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 60. R&D Systems Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 61. AssayPro Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 62. Abnova Corporation Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 63. Sino Biological Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 64. Biomatik Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 65. CUSABIO Technology Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 66. Affinity Biosciences Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 67. Creative Biolabs Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 68. Jingjie PTM BioLab Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 69. Beijing Solarbio Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global CD98 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD98 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CD98 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CD98 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CD98 Antibody Market Share by Region (2020-2025)
Table 8. Global CD98 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CD98 Antibody Market Share by Region (2026-2031)
Table 10. CD98 Antibody Market Trends
Table 11. CD98 Antibody Market Drivers
Table 12. CD98 Antibody Market Challenges
Table 13. CD98 Antibody Market Restraints
Table 14. Global CD98 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CD98 Antibody Market Share by Players (2020-2025)
Table 16. Global Top CD98 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD98 Antibody as of 2024)
Table 17. Ranking of Global Top CD98 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CD98 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CD98 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD98 Antibody, Product and Application
Table 21. Global Key Players of CD98 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD98 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CD98 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global CD98 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CD98 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global CD98 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CD98 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global CD98 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CD98 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America CD98 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CD98 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CD98 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CD98 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CD98 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CD98 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CD98 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CD98 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CD98 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD98 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CD98 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CD98 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CD98 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CD98 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CD98 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck CD98 Antibody Product
Table 49. Merck Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CD98 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Bioss Company Details
Table 57. Bioss Business Overview
Table 58. Bioss CD98 Antibody Product
Table 59. Bioss Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 60. Bioss Recent Development
Table 61. Proteintech Group Company Details
Table 62. Proteintech Group Business Overview
Table 63. Proteintech Group CD98 Antibody Product
Table 64. Proteintech Group Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 65. Proteintech Group Recent Development
Table 66. Aviva Systems Biology Company Details
Table 67. Aviva Systems Biology Business Overview
Table 68. Aviva Systems Biology CD98 Antibody Product
Table 69. Aviva Systems Biology Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 70. Aviva Systems Biology Recent Development
Table 71. Leading Biology Company Details
Table 72. Leading Biology Business Overview
Table 73. Leading Biology CD98 Antibody Product
Table 74. Leading Biology Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 75. Leading Biology Recent Development
Table 76. RayBiotech Company Details
Table 77. RayBiotech Business Overview
Table 78. RayBiotech CD98 Antibody Product
Table 79. RayBiotech Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 80. RayBiotech Recent Development
Table 81. ABclonal Technology Company Details
Table 82. ABclonal Technology Business Overview
Table 83. ABclonal Technology CD98 Antibody Product
Table 84. ABclonal Technology Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 85. ABclonal Technology Recent Development
Table 86. OriGene Technologies Company Details
Table 87. OriGene Technologies Business Overview
Table 88. OriGene Technologies CD98 Antibody Product
Table 89. OriGene Technologies Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 90. OriGene Technologies Recent Development
Table 91. Novus Biologicals Company Details
Table 92. Novus Biologicals Business Overview
Table 93. Novus Biologicals CD98 Antibody Product
Table 94. Novus Biologicals Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 95. Novus Biologicals Recent Development
Table 96. R&D Systems Company Details
Table 97. R&D Systems Business Overview
Table 98. R&D Systems CD98 Antibody Product
Table 99. R&D Systems Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 100. R&D Systems Recent Development
Table 101. AssayPro Company Details
Table 102. AssayPro Business Overview
Table 103. AssayPro CD98 Antibody Product
Table 104. AssayPro Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 105. AssayPro Recent Development
Table 106. Abnova Corporation Company Details
Table 107. Abnova Corporation Business Overview
Table 108. Abnova Corporation CD98 Antibody Product
Table 109. Abnova Corporation Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 110. Abnova Corporation Recent Development
Table 111. Sino Biological Company Details
Table 112. Sino Biological Business Overview
Table 113. Sino Biological CD98 Antibody Product
Table 114. Sino Biological Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 115. Sino Biological Recent Development
Table 116. Biomatik Company Details
Table 117. Biomatik Business Overview
Table 118. Biomatik CD98 Antibody Product
Table 119. Biomatik Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 120. Biomatik Recent Development
Table 121. CUSABIO Technology Company Details
Table 122. CUSABIO Technology Business Overview
Table 123. CUSABIO Technology CD98 Antibody Product
Table 124. CUSABIO Technology Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 125. CUSABIO Technology Recent Development
Table 126. Affinity Biosciences Company Details
Table 127. Affinity Biosciences Business Overview
Table 128. Affinity Biosciences CD98 Antibody Product
Table 129. Affinity Biosciences Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 130. Affinity Biosciences Recent Development
Table 131. Creative Biolabs Company Details
Table 132. Creative Biolabs Business Overview
Table 133. Creative Biolabs CD98 Antibody Product
Table 134. Creative Biolabs Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 135. Creative Biolabs Recent Development
Table 136. Jingjie PTM BioLab Company Details
Table 137. Jingjie PTM BioLab Business Overview
Table 138. Jingjie PTM BioLab CD98 Antibody Product
Table 139. Jingjie PTM BioLab Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 140. Jingjie PTM BioLab Recent Development
Table 141. Beijing Solarbio Company Details
Table 142. Beijing Solarbio Business Overview
Table 143. Beijing Solarbio CD98 Antibody Product
Table 144. Beijing Solarbio Revenue in CD98 Antibody Business (2020-2025) & (US$ Million)
Table 145. Beijing Solarbio Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. CD98 Antibody Picture
Figure 2. Global CD98 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD98 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global CD98 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CD98 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. CD98 Antibody Report Years Considered
Figure 15. Global CD98 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CD98 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CD98 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global CD98 Antibody Market Share by Players in 2024
Figure 19. Global Top CD98 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD98 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CD98 Antibody Revenue in 2024
Figure 21. North America CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CD98 Antibody Market Share by Country (2020-2031)
Figure 23. United States CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CD98 Antibody Market Share by Country (2020-2031)
Figure 27. Germany CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CD98 Antibody Market Share by Region (2020-2031)
Figure 35. China CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CD98 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CD98 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CD98 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 52. Bioss Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 53. Proteintech Group Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 54. Aviva Systems Biology Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 55. Leading Biology Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 56. RayBiotech Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 57. ABclonal Technology Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 58. OriGene Technologies Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 59. Novus Biologicals Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 60. R&D Systems Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 61. AssayPro Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 62. Abnova Corporation Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 63. Sino Biological Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 64. Biomatik Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 65. CUSABIO Technology Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 66. Affinity Biosciences Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 67. Creative Biolabs Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 68. Jingjie PTM BioLab Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 69. Beijing Solarbio Revenue Growth Rate in CD98 Antibody Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Pediatric Latex Double Hole Nasal Cannula Market Research Report 2025
May 16, 25
Global Pediatric Two-hole Nasal Cannula Market Research Report 2025
May 16, 25
Global Pediatric Nasal Oxygen Mask Market Research Report 2025
May 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232